Literature DB >> 23256765

Recommendations for identifying Crohn's disease patients with poor prognosis.

Pal Miheller1, Lajos S Kiss, Mark Juhasz, Michael Mandel, Peter L Lakatos.   

Abstract

Clinical presentation at diagnosis and the disease course of Crohn's disease is heterogeneous and variable over time. The majority of patients with Crohn's disease will develop at least one stricturing or perforating complication requiring surgery during follow-up. New data support a change in the natural history of the disease associated with the advent of biologicals and tailored treatment strategy. Therefore, it is important to identify patients at risk for disease progression as soon as possible. In recent years, much emphasis has been placed on determining important predictive factors. Complex evaluation of factors such as clinical and endoscopic presentation, fecal, serological and routine laboratory tests, and genetic factors is needed. This review summarizes the available evidence and will hopefully assist clinicians when choosing a treatment strategy in everyday practice.

Entities:  

Mesh:

Year:  2013        PMID: 23256765     DOI: 10.1586/eci.12.86

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  9 in total

1.  Serological Epithelial Component Proteins Identify Intestinal Complications in Crohn's Disease.

Authors:  Yunki Y Yau; Rupert W L Leong; Aviv Pudipeddi; Diane Redmond; Valerie C Wasinger
Journal:  Mol Cell Proteomics       Date:  2017-05-10       Impact factor: 5.911

2.  Incidence and clinical outcomes of intestinal Behçet's disease in Korea, 2011-2014: a nationwide population-based study.

Authors:  Minkyung Han; Yoon Suk Jung; Won Ho Kim; Jae Hee Cheon; Sohee Park
Journal:  J Gastroenterol       Date:  2016-12-27       Impact factor: 7.527

Review 3.  An update on granulomatous diseases of the oral tissues.

Authors:  Faizan Alawi
Journal:  Dent Clin North Am       Date:  2013-08-15

Review 4.  Inflammatory bowel disease course in Crohn's disease: is the natural history changing?

Authors:  Petra A Golovics; Michael D Mandel; Barbara D Lovasz; Peter L Lakatos
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

5.  Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics.

Authors:  Michael D Mandel; Mandel D Michael; Anita Bálint; Barbara D Lovász; László Gulácsi; Bálint Strbák; Petra A Golovics; Klaudia Farkas; Zsuzsanna Kürti; Blanka K Szilágyi; Anna Mohás; Tamás Molnár; Péter L Lakatos
Journal:  Eur J Health Econ       Date:  2014-05-16

6.  Taking Crohn's disease personally.

Authors:  Yehuda Chowers
Journal:  Rambam Maimonides Med J       Date:  2013-04-30

7.  Is faecal calprotectin equally useful in all Crohn's disease locations? A prospective, comparative study.

Authors:  Kamila Stawczyk-Eder; Piotr Eder; Liliana Lykowska-Szuber; Iwona Krela-Kazmierczak; Katarzyna Klimczak; Aleksandra Szymczak; Patrycja Szachta; Katarzyna Katulska; Krzysztof Linke
Journal:  Arch Med Sci       Date:  2015-04-23       Impact factor: 3.318

8.  The Association of Smoking and Surgery in Inflammatory Bowel Disease is Modified by Age at Diagnosis.

Authors:  Alexandra D Frolkis; Jennifer de Bruyn; Nathalie Jette; Mark Lowerison; Jordan Engbers; William Ghali; James D Lewis; Isabelle Vallerand; Scott Patten; Bertus Eksteen; Cheryl Barnabe; Remo Panaccione; Subrata Ghosh; Samuel Wiebe; Gilaad G Kaplan
Journal:  Clin Transl Gastroenterol       Date:  2016-04-21       Impact factor: 4.488

9.  Anti-Saccharomyces cerevisiae Antibody in Pediatric Crohn's Disease Patients without Mucosal Healing Is a Useful Marker of Mucosal Damage.

Authors:  Mi Jin Kim; Eunsil Kim; Ben Kang; Yoon Lee; Eun-Suk Kang; Yon Ho Choe
Journal:  Gut Liver       Date:  2021-09-15       Impact factor: 4.519

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.